Rebisufligene etisparvovec

DB16784InvestigationalGene Therapies

Rebisufligene etisparvovec: Overview.

Also known as
scAAV9.U1a.hSGSH · UX111
Code names
ABO-102

Resolves to

What you can answer from here — as of September 20, 2026

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in

Which other approved drugs treat the same conditions as Rebisufligene etisparvovec, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account